We previously found the aberrant methylation of NTRK3 in 60 % of colon adenomas and 67 % of colon adenocarcinomas, suggesting NTRK3 is a novel conditional tumor suppressor gene that is commonly inactivated in colorectal cancer by both epigenetic and genetic mechanisms [67]. This evidence concerns the gene NTRK3 and neoplasm.